Cetera Advisor Networks’s Xeris Biopharma Holdings XERS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $260K | Buy |
117,585
+595
| +0.5% | +$1.32K | ﹤0.01% | 2396 |
|
|
2023
Q4 | $275K | Buy |
116,990
+4,704
| +4% | +$11.1K | ﹤0.01% | 2302 |
|
|
2023
Q3 | $209K | Buy |
112,286
+1,449
| +1% | +$2.7K | ﹤0.01% | 2400 |
|
|
2023
Q2 | $290K | Buy |
110,837
+6,567
| +6% | +$17.2K | ﹤0.01% | 2109 |
|
|
2023
Q1 | $170K | Buy |
104,270
+19,894
| +24% | +$32.4K | ﹤0.01% | 2357 |
|
|
2022
Q4 | $112K | Sell |
84,376
-67
| -0.1% | -$89 | ﹤0.01% | 2366 |
|
|
2022
Q3 | $132K | Sell |
84,443
-33,047
| -28% | -$51.7K | ﹤0.01% | 1927 |
|
|
2022
Q2 | $181K | Buy |
117,490
+25,834
| +28% | +$39.8K | ﹤0.01% | 1883 |
|
|
2022
Q1 | $235K | Buy |
91,656
+6,281
| +7% | +$16.1K | ﹤0.01% | 1787 |
|
|
2021
Q4 | $250K | Buy |
+85,375
| New | +$250K | ﹤0.01% | 1726 |
|
|
2021
Q3 | – | Sell |
-44,740
| Closed | -$182K | – | 2043 |
|
|
2021
Q2 | $182K | Buy |
+44,740
| New | +$182K | ﹤0.01% | 1782 |
|